ENSIGN PEAK ADVISORS, INC – Regeneron Pharmaceuticals, Inc. Transaction History
ENSIGN PEAK ADVISORS, INC portfolio value:
$34.87M
portfolio value
ENSIGN PEAK ADVISORS, INC quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -15.76% | -9.47K shares | -652K | $688.87 | 50.62K |
Q2 2022 | share | Increase | +31.52% | 14.40K shares | 3.61M | $591.13 | 60.10K |
Q1 2022 | share | Decrease | -18.72% | -10.52K shares | -3.59M | $698.42 | 45.69K |
Q4 2021 | share | Decrease | -37.45% | -33.66K shares | -18.89M | $642.51 | 56.22K |
Q3 2021 | share | Decrease | -8.35% | -8.19K shares | -381K | $605.18 | 89.88K |
Q2 2021 | share | Decrease | -4.16% | -4.25K shares | 6.36M | $558.54 | 98.07K |
Q1 2021 | share | Decrease | -25.59% | -35.20K shares | -18.02M | $473.14 | 102.33K |
Q4 2020 | share | Decrease | -9.05% | -13.69K shares | -18.20M | $483.11 | 137.53K |
Q3 2020 | share | Decrease | -2.81% | -4.36K shares | -12.38M | $559.78 | 151.23K |
Q2 2020 | share | Increase | +82.59% | 70.38K shares | 55.42M | $623.65 | 155.59K |
Q1 2020 | share | Increase | +100.36% | 42.68K shares | 25.64M | $488.29 | 85.21K |
Q4 2019 | share | Increase | 0.00% | 42.53K shares | 15.97M | $375.48 | 42.53K |